Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine…
Recall D-0607-2018, part of FDA recall event 79457. See Pine Pharmaceuticals's company page.
Pine Pharmaceuticals, LLC started this Class III drug recall on Mar 5, 2018 (voluntary: firm initiated); FDA lists it as terminated, terminated Apr 23, 2018.
- Classification: Class III
- Started: Mar 5, 2018
- Status: Terminated
Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.
- Product
- Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01
- Quantity
- 136 units
- Lots and codes
- Lot#: 18098@1, Exp. 7/16/2018
- Distribution
- NY only
- Recalling firm
- Pine Pharmaceuticals, LLC, Tonawanda, NY, United States
- How the firm notified
- Letter
- FDA classified
- Mar 26, 2018
Newest first, one product per recall event; search them all
- Tropi-Phen (tropicamide 1%, phenylephrine 2.5%) ophthalmic solution, 5mL multi-use dropper, Rx only, Compounded by Pine…D-0063-2024 · Class II · Oct 2, 2023 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports